Compare, Analyse SHASUN PHARMA with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SHASUN PHARMA   MYLAN
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
MYLAN
Dec-18
SHASUN PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs943,364-   
Low Rs461,852-   
Sales per share (Unadj.) Rs214.21,548.1-  
Earnings per share (Unadj.) Rs5.342.0-  
Cash flow per share (Unadj.) Rs15.8331.9-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %1.40-  
Book value per share (Unadj.) Rs53.31,674.8-  
Shares outstanding (eoy) m56.62514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.7 19.4%   
Avg P/E ratio x13.162.0 21.1%  
P/CF ratio (eoy) x4.47.9 56.2%  
Price / Book Value ratio x1.31.6 84.1%  
Dividend payout %18.70-   
Avg Mkt Cap Rs m3,9581,341,863 0.3%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m2,1640-   
Avg. sales/employee Rs ThNM22,756.9-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM617.9-  
INCOME DATA
Net Sales Rs m12,127796,493 1.5%  
Other income Rs m2290-   
Total revenues Rs m12,356796,493 1.6%   
Gross profit Rs m1,009206,103 0.5%  
Depreciation Rs m594149,135 0.4%   
Interest Rs m41538,309 1.1%   
Profit before tax Rs m23018,660 1.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-73-2,969 2.4%   
Profit after tax Rs m30221,628 1.4%  
Gross profit margin %8.325.9 32.2%  
Effective tax rate %-31.7-15.9 199.0%   
Net profit margin %2.52.7 91.7%  
BALANCE SHEET DATA
Current assets Rs m6,884444,761 1.5%   
Current liabilities Rs m8,456324,280 2.6%   
Net working cap to sales %-13.015.1 -85.7%  
Current ratio x0.81.4 59.4%  
Inventory Days Days6284 73.7%  
Debtors Days Days10893 115.3%  
Net fixed assets Rs m4,970154,506 3.2%   
Share capital Rs m113424 26.7%   
"Free" reserves Rs m2,8750-   
Net worth Rs m3,020861,660 0.4%   
Long term debt Rs m1,817930,007 0.2%   
Total assets Rs m13,3472,311,307 0.6%  
Interest coverage x1.61.5 104.5%   
Debt to equity ratio x0.61.1 55.8%  
Sales to assets ratio x0.90.3 263.7%   
Return on assets %5.42.6 207.2%  
Return on equity %10.02.5 398.5%  
Return on capital %13.33.2 419.0%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Net fx Rs m3,6690-   
CASH FLOW
From Operations Rs m398165,511 0.2%  
From Investments Rs m-1,635-85,551 1.9%  
From Financial Activity Rs m1,309-77,105 -1.7%  
Net Cashflow Rs m711,371 5.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 70.68 Rs / USD

Compare SHASUN PHARMA With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare SHASUN PHARMA With: FRESENIUS KABI ONCO.  DR. DATSONS LABS  TORRENT PHARMA  BIOCON   FULFORD INDIA  



Today's Market

Rising Inflation and Onion Effect: Your Inside Scoop on the Markets(Podcast)

Stock markets remained rangebound this week too. Macroeconomic news globally and domestically remained the focus of the week.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020 (Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

Make the Most of the Smallcap Rebound with These Stocks (Profit Hunter)

Dec 3, 2019

Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.

What Is the IPO Euphoria Signaling Us About the Markets? (The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 8-QTR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS